| Items | CAS |
| Letrozole powder | 112809-51-5 |
| Anastrozole (Arimidex) powder | 120511-73-1 |
| Formestane (Lentaron) powder | 566-48-3 |
| Exemestane (Aromasin) powder | 107868-30-4 |
The Aromatase Inhibitor powders are produced in strict accordance with cGMP guidelines, 100% quality assurance, with purity no less than 98%.
| Oral Steroids | Content per pill | Pills per bottle |
| Anastrozole pills | 1mg | 100 |
| Letrozole pills | 2.5mg | 100 |
| Exemestane pills | 25mg | 100 |
Aromatase inhibitors (AI) reduce estrogen levels by blocking aromatase in adipose tissue, which converts other hormones into estrogen. The AIs drugs include:
Aromatase Inhibitors (AIs) inhibits the action of aromatase enzymes by attaching drug molecules to them instead of testosterone.
Anastrozole;
Letrozole;
Exemestane.
● Aromatase Inhibitors most common side effects are symptoms of menopause, such as hot flashes, night sweats, and vaginal dryness.
● Aromatase Inhibitors tend to speed up bone thinning, which can lead to osteoporosis. People with osteoporosis are more likely to have broken bones.
● Aromatase Inhibitors drugs can cause muscle and joint pain. This side effect can be serious enough to cause some women to stop taking the drugs.
● Aromatase Inhibitors may raise cholesterol. Women with pre-existing heart disease who take an AI may be at higher risk of having a heart problem.